Literature DB >> 17105603

The efficacy of photochemical treatment with methylene blue and light for the reduction of Trypanosoma cruzi in infected plasma.

N Gironés1, J L Bueno, J Carrión, M Fresno, E Castro.   

Abstract

BACKGROUND AND OBJECTIVES: Chagas disease is a transfusion-transmitted infection. This study evaluates the efficacy of a methylene blue (MB) and light system for reducing the viability of Trypanosoma cruzi in plasma. MATERIALS AND METHODS Trypanosoma cruzi strains were spiked in plasma pools. Treatment arms included combined filtration, MB, light and freezing. Post-treatment parasite viability was assayed through in vitro cultures and in vivo inoculation in inducible nitric oxide synthase- and interferon-gamma-receptor-deficient mice.
RESULTS: The filtration, MB and light combined treatment showed a log reduction of > 3.4 in in vitro cultures, and log reductions that ranged from > 4.9 to > 5.8 in deficient mice inoculated with different T. cruzi strains.
CONCLUSION: The treatment of plasma units with the MB and light system reduces the T. cruzi burden and could be useful in preventing transfusion-transmitted Chagas disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17105603     DOI: 10.1111/j.1423-0410.2006.00840.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  11 in total

Review 1.  Chagas disease and transfusion medicine: a perspective from non-endemic countries.

Authors:  Andrea Angheben; Lucia Boix; Dora Buonfrate; Federico Gobbi; Zeno Bisoffi; Simonetta Pupella; Giorgio Gandini; Giuseppe Aprili
Journal:  Blood Transfus       Date:  2015-10       Impact factor: 3.443

Review 2.  Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use.

Authors:  Americo Cicchetti; Alexandra Berrino; Marina Casini; Paola Codella; Giuseppina Facco; Alessandra Fiore; Giuseppe Marano; Marco Marchetti; Emanuela Midolo; Roberta Minacori; Pietro Refolo; Federica Romano; Matteo Ruggeri; Dario Sacchini; Antonio G Spagnolo; Irene Urbina; Stefania Vaglio; Giuliano Grazzini; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2016-07       Impact factor: 3.443

3.  Anti-Trypanosoma cruzi effect of the photodynamic antiparasitic chemotherapy using phenothiazine derivatives as photosensitizers.

Authors:  Artur F S Barbosa; Ivanilson P Santos; Gustavo M P Santos; Tanira M Bastos; Vinícius P C Rocha; Cássio S Meira; Milena B P Soares; Ivan R Pitta; Antônio Luiz Barbosa Pinheiro
Journal:  Lasers Med Sci       Date:  2019-05-12       Impact factor: 3.161

4.  Main Properties of the THERAFLEX MB-Plasma System for Pathogen Reduction.

Authors:  Jerard Seghatchian; Wilhelm G Struff; Stefan Reichenberg
Journal:  Transfus Med Hemother       Date:  2011-01-27       Impact factor: 3.747

5.  Thrombin Generation Capacity of Methylene Blue-Treated Plasma Prepared by the Theraflex MB Plasma System.

Authors:  Ute Gravemann; Manuela Kusch; Herbert Koenig; Harald Mohr; Thomas H Mueller
Journal:  Transfus Med Hemother       Date:  2009-03-04       Impact factor: 3.747

6.  Photoinactivation of Trypanosoma cruzi in red cell suspensions with thiopyrylium.

Authors:  Stephen J Wagner; Andrey Skripchenko; Jeanne Salata; Lisa J Cardo
Journal:  Transfus Apher Sci       Date:  2007-08-14       Impact factor: 1.764

7.  Nonimmune Cells Contribute to Crosstalk between Immune Cells and Inflammatory Mediators in the Innate Response to Trypanosoma cruzi Infection.

Authors:  Maria Pilar Aoki; Eugenio Antonio Carrera-Silva; Henar Cuervo; Manuel Fresno; Núria Gironès; Susana Gea
Journal:  J Parasitol Res       Date:  2011-08-18

Review 8.  Trypanosoma cruzi infection in transfusion medicine.

Authors:  Lina Andrea Gómez; Fredy R S Gutierrez; Oscar Andres Peñuela
Journal:  Hematol Transfus Cell Ther       Date:  2019-03-21

9.  Inactivation of Ebola virus and Middle East respiratory syndrome coronavirus in platelet concentrates and plasma by ultraviolet C light and methylene blue plus visible light, respectively.

Authors:  Markus Eickmann; Ute Gravemann; Wiebke Handke; Frank Tolksdorf; Stefan Reichenberg; Thomas H Müller; Axel Seltsam
Journal:  Transfusion       Date:  2018-05-06       Impact factor: 3.157

10.  Preservation of anti-SARS-CoV-2 neutralising antibodies in convalescent plasma after pathogen reduction with methylene blue and visible light.

Authors:  Luis Larrea; Emma Castro; Laura Navarro; Belén Vera; Clara Francés-Gómez; Beatriz Sánchez-Sendra; Ángel Giménez; Emilia Castelló; Miriam Collado; María-Jesus Vayá; Vicente Mirabet; Virginia Callao; María-Isabel Ortiz-de-Salazar; Roberto Roig; Ron Geller; Cristina Arbona
Journal:  Blood Transfus       Date:  2021-08-02       Impact factor: 5.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.